Leith D K, Hansen E J, Wilson R M, Krause D C, Baseman J B
Infect Immun. 1983 Feb;39(2):844-50. doi: 10.1128/iai.39.2.844-850.1983.
A selective enrichment technique was used to isolate a hemadsorption-positive revertant of a hemadsorption-negative mutant strain of Mycoplasma pneumoniae. This hemadsorption-positive revertant was shown to have simultaneously regained both the ability to attach to neuraminidase-sensitive receptors on the tracheal ring respiratory epithelium in vitro and the ability to synthesize three virulent-strain-specific proteins which were not synthesized by the hemadsorption-negative mutant. Despite the persistence of the revertant in hamster lung tissue for 9 to 12 weeks postinfection, no cytopathology was observed. Intranasal inoculation of the revertant provided limited protection against a challenge dose of virulent M. pneumoniae.
采用一种选择性富集技术,从肺炎支原体血吸附阴性突变株中分离出一株血吸附阳性回复株。该血吸附阳性回复株在体外已同时恢复了附着于气管环呼吸上皮细胞上对神经氨酸酶敏感受体的能力,以及合成三种毒力株特异性蛋白的能力,而血吸附阴性突变株无法合成这些蛋白。尽管感染后9至12周回复株在仓鼠肺组织中持续存在,但未观察到细胞病变。经鼻接种该回复株对强毒肺炎支原体攻击剂量提供的保护有限。